Venture Fund I. L.p. Astellas is 10% at Epizyme, Inc. (EPZM). They have made 1 open-market trade across 1 company since 2013, most recently 2013-06-05.
CIK 0001576141
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $230K since 2013, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EPZM | 634,920 | $933K |
Shares reported on the most recent Form 4, priced at the 2013-06-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EPZM | BUY | 2013-06-05 | 2013-06-06 | $15.00 | $230K | -37.3% | -2.4% | -2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.